PHARMACOKINETICS OF DAUNORUBICIN AND DOXORUBICIN IN PLASMA AND LEUKEMIC-CELLS FROM PATIENTS WITH ACUTE NONLYMPHOBLASTIC LEUKEMIA

被引：42

作者：

PAUL, C

LILIEMARK, J

TIDEFELT, U

GAHRTON, G

PETERSON, C

机构：

[1] KAROLINSKA INST,S-10401 STOCKHOLM 60,SWEDEN

[2] KAROLINSKA HOSP,DEPT CLIN PHARMACOL,S-10401 STOCKHOLM 60,SWEDEN

[3] KAROLINSKA INST,HUDDINGE,SWEDEN

来源：

THERAPEUTIC DRUG MONITORING | 1989年 / 11卷 / 02期

关键词：

D O I：

10.1097/00007691-198903000-00004

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：140 / 148

页数：9

共 24 条

[1]

ANDERSSON B, 1979, CANCER CHEMOTH PHARM, V2, P15

[2]

ANDERSSON B, 1980, CANCER CHEMOTH PHARM, V4, P205

[3]

ANDERSSON B, 1979, CANCER CHEMOTH PHARM, V2, P159

[4]

ARCAMONE F, 1981, DOXORUBICIN ANTICANC, V17

[5] CELLULAR PHARMACODYNAMICS OF SEVERAL ANTHRACYCLINE ANTIBIOTICS [J].

BACHUR, NR ;

STEELE, M ;

MERIWETHER, WD ;

HILDEBRAND, RC .

JOURNAL OF MEDICINAL CHEMISTRY, 1976, 19 (05) :651-654

[6] CELLULAR UPTAKE AND METABOLISM OF DAUNORUBICIN AS DETERMINED BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY - APPLICATION TO L1210 CELLS [J].

BAURAIN, R ;

ZENEBERGH, A ;

TROUET, A .

JOURNAL OF CHROMATOGRAPHY, 1978, 157 (SEP) :331-336

[7]

CHLEBOWSKI RT, 1979, WESTERN J MED, V131, P364

[8]

DEPREZDECAMPENEERE D, 1979, CANCER CHEMOTH PHARM, V2, P25

[9] DOXORUBICIN CARDIAC TOXICITY MANIFESTING 7 YEARS AFTER TREATMENT - CASE-REPORT AND REVIEW [J].

FRETER, CE ;

LEE, TC ;

BILLINGHAM, ME ;

CHAK, L ;

BRISTOW, MR .

AMERICAN JOURNAL OF MEDICINE, 1986, 80 (03) :483-485

[10]

HULHOVEN R, 1979, CANCER CHEMOTH PHARM, V3, P243

← 1 2 3 →